Reduction of Phosphorylated Tau in Alzheimer’s Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil
Journal of Alzheimer's Disease · 06.12.2023 · 96 (4) · 1695-1709
DOI: 10.3233/jad-230551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 06.12.2023. Verfasst von Elisa Giunti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Research Education and Clinical Center, Bedford VA Healthcare System, Bedford, MA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: BLRD VA, Medical Research Council, NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) is the most predominant form of dementia. Rho-associated coiled coil kinase (ROCK) inhibitor, fasudil, is one of the candidate drugs against the AD progression.
Objective
We aimed to investigate possible changes of AD associated markers in three-dimensional neuro-spheroids (3D neuro-spheroids) generated from induced pluripotent stem cells derived from AD patients or healthy control subjects (HC) and to determine the impact of pharmacological intervention with the ROCK inhibitor fasudil.
Methods
We treated 3D neuro-spheroids with fasudil and tested the possible effect on AD markers by ELISA, transcriptomic and proteomic analyses.
Results
Transcriptomic analysis revealed a reduction in the expression of AKT serine/threonine-protein kinase 1 (AKT1) in AD neuro-spheroids, compared to HC. This decrease was reverted in the presence of fasudil. Proteomic analysis showed up- and down-regulation of proteins related to AKT pathway in fasudil-treated neuro-spheroids. We found an evident increase of phosphorylated tau at four different residues (pTau181, 202, 231, and 396) in AD compared to HC-derived neuro-spheroids. This was accompanied by a decrease of secreted clusterin (clu) and an increase of intracellular clu levels in AD patient-derived neuro-spheroids. Increases of phosphorylated tau in AD patient-derived neuro-spheroids were suppressed in the presence of fasudil.
Conclusions
Fasudil modulates clu protein levels and enhances AKT1 that results in the suppression of AD associated tau phosphorylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Geriatric Research Education and Clinical Center, Bedford VA Healthcare System, Bedford, MA, USA.
- Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
- Department of Neurology, Tufts Medical Center, Boston, MA, USA.
- Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, Boston, MA, USA.
- Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
- Department of Biological Sciences, Kennedy College of Sciences, University of Massachusetts, Lowell, MA, USA.
Förderung
- BLRD VA
- Medical Research Council
- NIA NIH HHS
Zitieren
APA
Giunti, E., Collu, R., Daley, S., Querfurth, H., Morin, P., Killick, R., Melamed, R. D., & Xia, W. (2023). Reduction of Phosphorylated Tau in Alzheimer’s Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil. Journal of Alzheimer's Disease, 96(4), 1695-1709. https://doi.org/10.3233/jad-230551
Vancouver
Giunti E, Collu R, Daley S, Querfurth H, Morin P, Killick R, et al. Reduction of Phosphorylated Tau in Alzheimer’s Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil. Journal of Alzheimer's Disease. 2023;96(4):1695-1709. doi:10.3233/jad-230551
BibTeX
@article{Giunti2023,
author = {Giunti, Elisa and Collu, Roberto and Daley, Sarah and Querfurth, Henry and Morin, Peter and Killick, Richard and Melamed, Rachel D and Xia, Weiming},
title = {Reduction of Phosphorylated Tau in Alzheimer’s Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil},
journal = {Journal of Alzheimer's Disease},
year = {2023},
volume = {96},
number = {4},
pages = {1695--1709},
doi = {10.3233/jad-230551}
}
EUVIMED